Immunology and Microbiology
Dog
100%
Leishmania
62%
Leishmaniasis
60%
Parasite
57%
ELISA
32%
Leishmania infantum
29%
Antigen
28%
Visceral Leishmaniasis
26%
Skin
23%
Vaccine Efficacy
22%
Trypanosoma Cruzi
19%
Immune Response
19%
Immunity
18%
Sirolimus
18%
Sample
17%
Host
16%
Immunoglobulin A
15%
Real-Time Polymerase Chain Reaction
14%
Macrophage
14%
Cat
13%
Adjuvant
13%
Mycobacteria
13%
Cancer Immunotherapy
13%
Intravenous Immunoglobulin
13%
Liver
11%
Adoptive Immunity
11%
Growth
11%
Parasite Load
11%
Monospecific Antibody
10%
Heat
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
DNA Vaccine
10%
Protozoa
9%
Incidence
9%
Tissues
9%
Delayed Hypersensitivity
9%
down Regulation
8%
TLR9
8%
Lung
8%
Monocyte
8%
Mouse Model
8%
Development
8%
Isotype
7%
Dose
7%
Upregulation
7%
Insect
7%
Cells
7%
Promastigote
7%
Zoonotic
6%
TLR3
6%
Medicine and Dentistry
Spleen
32%
Infection
31%
Parasite (Microbiology)
25%
Diseases
21%
In Vitro
21%
Rapamycin
18%
Leishmania
18%
Macrophage
17%
Vaccine
17%
Visceral Leishmaniasis
17%
Chemotherapeutic Agent
16%
Drug
16%
Chagas Disease
16%
Immunity
14%
Dichloroacetic Acid
13%
Glucose
13%
Amphotericin B
13%
Mycobacterium
13%
Cancer Immunotherapy
13%
Immunoglobulin
13%
Immune Response
12%
Parasitic Disease
12%
Therapeutic Procedure
10%
Tumor Necrosis Factor
10%
Leishmaniasis
10%
Glycon
9%
Lonidamine
9%
Protein
9%
Cytokine
9%
Growth
9%
Cytokine Response
8%
Antigen Presenting Cell
8%
Combination Therapy
8%
Dendrimer
7%
Leishmania infantum
7%
Monocyte
6%
Target Tissue
6%
Acid
6%
Adenosine Triphosphate
6%
Trypanosoma Cruzi
6%
17-Dimethylaminoethylamino-17-Demethoxygeldanamycin
6%
Heat Shock Protein 90
6%
Global Health
5%
Toxicity
5%
Plasmid
5%
Skin
5%
DNA Vaccine
5%
Upregulation
5%
Popliteal Lymph Node
5%
Liver
5%